Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Big Digital Energy, Inc.WIZP · Entity 673 | Director | August 11, 2020 | August 13, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Big Digital Energy, Inc.
Report date August 11, 2020 · Filed August 13, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 100,000 |
Reported balance
After 2020-08-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-11 · Grant · Acquired 100,000 · Balance 100,000 F1: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2: Vest quarterly over a two year period commencing on the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock.
F2: Vest quarterly over a two year period commencing on the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2020 Filed Aug 13, 2020 20:00 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantRestricted Stock Units (RSU) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-021850 · ownership.xml · derivative · entry 1 Belkin Michael · CIK 0001580801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2 · derivative.exercise_date: Vest quarterly over a two year period commencing on the date of the grant. F2 · derivative.expiration_date: Vest quarterly over a two year period commencing on the date of the grant. Read SEC document |
| June 30, 2019 Filed Sep 16, 2019 21:14 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantRestricted Stock Units (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-018172 · ownership.xml · derivative · entry 2 Belkin Michael · CIK 0001580801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 12,500 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2 · derivative.exercise_date: On March 31, 2019, the reporting person was granted 100,000 restricted stock units, vesting quarterly over a two year period with the first installment issued on June 30, 2019. F2 · derivative.expiration_date: On March 31, 2019, the reporting person was granted 100,000 restricted stock units, vesting quarterly over a two year period with the first installment issued on June 30, 2019. Read SEC document |
| June 30, 2019 Filed Sep 16, 2019 21:14 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-19-018172 · ownership.xml · nonDerivative · entry 1 Belkin Michael · CIK 0001580801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. Read SEC document |
| March 31, 2019 Filed Apr 3, 2019 00:23 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantRestricted Stock Units (RSU) · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005667 · ownership.xml · derivative · entry 1 Belkin Michael · CIK 0001580801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a right to receive one share of Wize Pharma, Inc. common stock. F2 · derivative.exercise_date: Vest quarterly over a two year period commencing on the date of grant. F2 · derivative.expiration_date: Vest quarterly over a two year period commencing on the date of grant. Read SEC document |
| April 04, 2018 Filed Jun 4, 2018 21:06 UTC | Big Digital Energy, Inc. WIZP · Entity 673 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001213900-18-007201 · f4040418belkin_wizepharma.xml · derivative · entry 1 Belkin Michael · CIK 0001580801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-04-04 F2 · price: The Stock Option was granted as compensation for services as a director of the Issuer. F1 · derivative.exercise_date: The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.